Kangmei Biotechnology

Kangmei Biotechnology Group was founded in 2000. It is a high-tech enterprise specializing in the research and development, production, and sales of biomedical products. In 2016, it was listed on the New Third Board (stock code: 835541). Its subsidiaries include Beijing Kangmei Tianhong Biotechnology Co., Ltd., Wuhan Changli Biotechnology Co., Ltd., Shanghai Youyi Biotechnology Co., Ltd., and Changzhou Aifukang Biotechnology Co., Ltd. The company's products cover fields such as diagnostic reagents, medical devices, and medical information, and it has formed a complete industrial chain from research and development, production to sales and technical support. The company's product "Helicobacter pylori urease antibody detection kit (colloidal gold method)" has a domestic market share of over 60%, becoming a product for such physical examination items in major hospitals. After years of knowledge accumulation, it has obtained dozens of authorized and pending invention patents. The production base covers an area of more than 15,000 square meters with a good office environment. The company has multiple categories of specialized production workshops and quality control centers for nucleic acid diagnostic reagents, gold-labeled rapid diagnostic reagents, clinical biochemical diagnostic reagents, and diagnostic analytical instruments. It has passed the national in vitro diagnostic reagent quality system assessment and obtained nearly 100 production license certificates for Class II and Class III products. It has established a strong quality control system from raw material selection, manufacturing to after-sales service. About Kangmei Biotechnology? Scientific research team Kangmei Biotechnology has a research and development team led by outstanding scientists, with experts in clinical medicine, immunology, molecular biology, microbiology, medical laboratory science, and other fields as the backbone. Some experts have become national academic leaders and key members of industry organizations such as the Chinese Medical Association. ? Main products The company's products cover fields such as diagnostic reagents, medical devices, and medical information, and it has formed a complete industrial chain from research and development, production to sales and technical support. The company's product "Helicobacter pylori urease antibody detection kit (colloidal gold method)" has a domestic market share of over 60%, becoming a product for such physical examination items in major hospitals. After years of knowledge accumulation, it has obtained dozens of authorized and pending invention patents. ? Customer resources Kangmei Biotechnology has established a high-quality professional promotion team and has established good business relationships with nearly 3,000 medical institutions nationwide. Its products cover all provinces and municipalities directly under the Central Government in China, forming a nationwide sales network. ? Corporate culture At Kangmei Biotechnology, we advocate simplicity, equality, innovation, and pragmatism; we focus on self-growth and free sharing; we implement a matrix-flat and culturally relaxed management style; our philosophy is to build a better life with a responsible attitude. ? Production base The production base covers an area of more than 15,000 square meters with a good office environment. The company has multiple categories of specialized production workshops and quality control centers for nucleic acid diagnostic reagents, gold-labeled rapid diagnostic reagents, clinical biochemical diagnostic reagents, and diagnostic analytical instruments. It has passed the national in vitro diagnostic reagent quality system assessment and obtained nearly 100 production license certificates for Class II and Class III products. It has established a strong quality control system from raw material selection, manufacturing to after-sales service. ? We provide 1. Good career development channels, broad career promotion paths, and a perfect mentorship system; 2. A flat management atmosphere, a relaxed working environment, warm working relationships, and complete logistical support; 3. Employee accommodation is provided, relieving your worries in first-tier cities.